Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells

BACKGROUND: The administration of menopausal hormone therapy (MHT) in women with uterine leiomyomas is still debated. The purpose of this article is to study the proliferation and apoptosis of uterine leiomyoma cells under the impact of selective estrogen receptor modulator (SERM) combined with estr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Shu-Lan, Wang, Rui, Xue, Xue, Zhao, Lan-Bo, Tuo, Xiao-Qian, Ma, Si-Jia, Liang, Dong-Xin, Wang, Yi-Ran, Feng, Xue, Li, Qing, Wang, Qi, Han, Lu, Li, Qi-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798564/
https://www.ncbi.nlm.nih.gov/pubmed/35117904
http://dx.doi.org/10.21037/tcr-19-3022a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798564/
https://www.ncbi.nlm.nih.gov/pubmed/35117904
http://dx.doi.org/10.21037/tcr-19-3022a

Ejemplares similares